Yoda Pharmaceuticals Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-315.73	-192.19	-85.32	-43.85
Depreciation & Amortization	1.95	1.35	0.84	0.76
Stock-Based Compensation	-	-	0.5	-
Other Operating Activities	-0.98	1.81	-2.35	0.01
Change in Accounts Receivable	4.02	1.25	0.06	-0.05
Change in Accounts Payable	19.26	-6.12	19.47	-1.27
Change in Other Net Operating Assets	8.69	6.47	-9.91	0.15
Operating Cash Flow	-282.79	-187.43	-76.71	-44.24
Capital Expenditures	-1.76	-2.32	-4.34	-
Investment in Securities	-48.45	242.22	-296.97	-
Other Investing Activities	-0.1	-0.08	-	-0.01
Investing Cash Flow	-50.3	239.83	-301.3	-0.01
Issuance of Common Stock	524.66	465.66	0.02	-
Other Financing Activities	-	-	-	9.22
Financing Cash Flow	524.27	465.66	380.16	9.22
Foreign Exchange Rate Adjustments	0.38	16.28	13.42	2.34
Net Cash Flow	191.56	534.34	15.57	-32.69
Free Cash Flow	-284.55	-189.75	-81.05	-44.24
Free Cash Flow Per Share	-3.92	-4.45	-6.81	-3.79
Cash Interest Paid	0.02	-	0.04	-
Cash Income Tax Paid	0.82	-	1.09	0
Levered Free Cash Flow	-	-139.28	-51.9	-
Unlevered Free Cash Flow	-	-139.28	-51.88	-
Change in Working Capital	31.97	1.6	9.62	-1.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.